These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27703495)

  • 1. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.
    Liu J; Hua P; Hui L; Zhang LL; Hu Z; Zhu YW
    Exp Ther Med; 2016 Oct; 12(4):2109-2119. PubMed ID: 27703495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis.
    Zhang DQ; Zhou CK; Chen SZ; Yang Y; Shi BK
    Oncol Lett; 2017 Jul; 14(1):1115-1122. PubMed ID: 28693282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of pathway-related modules in high-grade osteosarcoma based on topological centrality of network strategy.
    Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2209-20. PubMed ID: 27338044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes and pathways associated with retinoblastoma based on co-expression network analysis.
    Wang QL; Chen X; Zhang MH; Shen QH; Qin ZM
    Genet Mol Res; 2015 Dec; 14(4):16151-61. PubMed ID: 26662407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genes in ulcerative colitis associated colorectal cancer based on centrality analysis of co-expression network.
    Zhu J; Li C; Ji W
    Neoplasma; 2015; 62(5):756-64. PubMed ID: 26278145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
    Liu F; Li H; Chang H; Wang J; Lu J
    Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes in peripheral blood mononuclear cells for the diagnosis of hepatocellular carcinoma using a weighted gene co-expression network analysis.
    Ye Z; Zeng Z; Shen Y; Chen Z
    Exp Ther Med; 2020 Aug; 20(2):890-900. PubMed ID: 32742331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing.
    Zheng Y; Long J; Wu L; Zhang H; Li L; Zheng Y; Wang A; Lin J; Yang X; Sang X; Hu K; Pan J; Zhao H
    Oncotarget; 2017 Sep; 8(36):60358-60367. PubMed ID: 28947976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
    Cai C; Wang W; Tu Z
    J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
    Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
    Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data.
    Zeng Z; Cao Z; Tang Y
    Oncol Lett; 2020 Nov; 20(5):231. PubMed ID: 32968453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
    Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
    Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.